Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Expects Medicare Discount Card Program To Continue Past 2006

This article was originally published in The Pink Sheet Daily

Executive Summary

"I'll be surprised" if the card program is shut down on schedule, Medco CEO tells analysts. Any extension is good for Medco, he says. PBM is passing on all brand rebates under Medicare card; profits come from enrollment fees and generics.

You may also be interested in...



“U Share” Cuts Mail Order Prices For Pfizer Drugs: Medicare Discount Update

Prices for most other Medicare-endorsed drug discount cards remain stable in the May 24 pricing update. An exception is Omnicare subsidiary PBM Plus, which dropped retail prices $2.25 on many brands, giving it the best price on Crestor and some other products.

Medco Has 600,000 Seniors In Medicare Card Plans; Enrollment Continues

Medco has over 600,000 seniors signed up for its many Medicare-endorsed discount card programs, CEO David Snow told the Banc of America Securities conference in Las Vegas May 20

More Like Untouchable? US Medicare ‘Protected Classes’ Stay Protected – Again

A decision made more than 15 years ago by CMS to require drug insurance plans to cover all drugs for six specific diseases has proven impervious to change. But will the protected classes remain if Part D is reformed more broadly?

Topics

UsernamePublicRestriction

Register

PS059645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel